4.8 Review

PROTAC degraders as chemical probes for studying target biology and target validation

期刊

CHEMICAL SOCIETY REVIEWS
卷 51, 期 18, 页码 7971-7993

出版社

ROYAL SOC CHEMISTRY
DOI: 10.1039/d2cs00478j

关键词

-

资金

  1. Structural Genomics Consortium (SGC), a registered charity - Bayer A. G. [1097737]
  2. Boehringer Ingelheim
  3. Bristol Myers Squibb
  4. Genentech
  5. Genome Canada through Ontario Genomics Institute
  6. EU/EFPIA/OICR/McGill/KTH/Diamond Innovative Medicines Initiative 2 Joint Undertaking [EUbOPEN grant] [875510]
  7. Janssen
  8. Merck KGaA
  9. Pfizer
  10. Takeda
  11. German Cancer Research Center DKTK
  12. Frankfurt Cancer Institute (FCI)
  13. Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [CRC1430, 424228829]

向作者/读者索取更多资源

Small molecule degraders called PROTACs have emerged as a promising pharmacological modality for protein degradation and have the potential to expand the proteome that can be targeted by small molecules. Their development and characterization require additional assays and specific quality criteria compared to conventional chemical probes. This review discusses recent progress in the development of assay systems and suggests a set of criteria for high-quality PROTACs as chemical probes.
Small molecule degraders such as PROTACs (PROteolysis TArgeting Chimeras) have emerged as new promising pharmacological modalities and the first PROTAC drug candidates are now studied clinically. The catalytic properties of PROTACs, acting as chemical degraders of a protein of interest (POI), represent an attractive new strategy for drug development. The development and characterization of PROTACs requires an array of additional assay systems that track the degradation pathway leading ultimately to degradation of the POI, identifying critical steps for PROTAC optimization. In addition to their exciting translational potential, PROTACs represent versatile chemical tools that considerably expanded our chemical biology toolbox and significantly enlarged the proteome that can be modulated by small molecules. Similar to conventional chemical probes, PROTACs used as chemical probes in target validation require comprehensive characterization. As a consequence, PROTAC-specific quality criteria should be defined by the chemical biology community. These criteria need to comprise additional or alternative parameters compared to those for conventional occupancy-driven chemical probes, such as the maximum level of target degradation (D-max), confirmation of a proteasome dependent degradation mechanism and, importantly, also kinetic parameters of POI degradation. The kinetic aspects are particularly relevant for PROTACs that harbor covalent binding moieties. Here, we review recent progress in the development of assay systems for PROTAC characterization and suggest a set of criteria for PROTACs as high quality chemical probes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据